An investigation into the science — and the gaps in the science — behind BPC-157 and MOTS-c, including a look at the risks people rarely ask about.
Listen →Ralph DeFronzo, M.D. — the researcher who helped bring metformin to the US and developed SGLT2 inhibitors — walks through the pathophysiology of insulin resistance across muscle, liver, and fat, and how it's measured, prevented, diagnosed, and treated.
Listen →Ralph DeFronzo, M.D. walks through the pathophysiology of insulin resistance across muscle, liver, and fat, and how it's measured, prevented, diagnosed, and treated.
Listen →NYT's David Dodge and McGill's Jonathan Jarry unpack why injectable peptide therapy caught fire in the wellness world despite thin safety data.
Listen →